ARYA Sciences Acquisition Corp III
Completed
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $125M
- Underwriters
- Focus
- Healthcare, Life Sciences
- SEC Filings
- 1808805
- Public Embarc Page
- https://embarc.com/capital/spac/1808805/ARYA/arya-sciences-acquisition
- IPO Ticker
- ARYA
SPAC Leadership
Information on the SPAC leadership.
- ChairmanJoseph Edelman
- Chief Executive Officer and DirectorAdam Stone
- Chief Financial Officer and DirectorMichael Altman, CFA
- Chief Business OfficerKonstantin Poukalov
- DirectorTodd Wider
- DirectorBradley L. Campbell
- DirectorSaqib Islam
Target Information
Information on the SPAC target for merger.
- Company
- Nautilus Biotechnology
- Presentation
- Investor Presentation (SEC) on 2021-02-08
- New Ticker
- NAUT
- Description
- Nautilus Biotechnology is "a company pioneering a single-molecule protein analysis platform for quantifying the human proteome."